Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

W91YU016P0030

Contract

Obligated and Ceiling

Obligated (net)
$108,863.73
Ceiling (potential value, not spending)
$108,863.73
Current value
$108,863.73
Gross positive obligations
$167,595.64

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W91YU016P0030
Award type code
B
Actions
11 · Nov 13, 2015 to Mar 5, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Mar 5, 2020FY2020P00010C−$50,591.54
—
Oct 25, 2019FY2020P00009C$33,519.13
—
Aug 13, 2019FY2019P00008G$0.00
—
Oct 23, 2018FY2019P00007C$33,519.13
—
Sep 19, 2018FY2018P00006G$0.00
—
Oct 12, 2017FY2018P00005C$33,519.13
—
Jul 28, 2017FY2017P00004G$0.00
—
Oct 28, 2016FY2017P00003G$33,519.13
—
Oct 26, 2016FY2017P00002G$0.00
—
Sep 24, 2016FY2016P00001C−$8,140.37
—
Nov 13, 2015FY20160—$33,519.12
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.